Evaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder

Recruiting

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(10 sites)

United States

Tarzana Treatment Centers, Tarzana, California

Gateway Community Services, Jacksonville, Florida

IBIS Behavioral Health, Tampa, Florida

Ruth M. Rothstein CORE Center, Chicago, Illinois

The Gibson Center for Behavioral Change, Cape Girardeau, Missouri

Prisma Health, Greenville, South Carolina

Vanderbilt University Medical Center, Nashville, Tennessee

University of Utah, Salt Lake City, Utah

Marshall Health, Huntington, West Virginia

Healthy Minds/Chestnut Ridge, Morgantown, West Virginia